Plain-English translation of NCT06847399 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a medication called to see if it can help people with binge eating disorder and obesity. is given as a weekly injection. You'll be randomly assigned to receive either the medication, a comparison medication, or a placebo (inactive treatment), and all participants will also receive therapy support to help with eating behaviors.
Binge eating disorder is a serious condition that affects many people, and current treatment options are limited. This study aims to see if this medication can reduce binge eating episodes and support healthy weight management better than existing options.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either a weekly injection of the new medication, a comparison medication, or a placebo—along with guided therapy sessions to help with binge eating behaviors. You'll attend regular study visits to report your progress, have your weight monitored, and complete interviews about your eating patterns. The study involves learning to self-inject (or receiving injections from a trained staff member if you cannot inject yourself) and taking daily oral capsules as directed.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States